Viking Therapeutics, Inc. (VKTX)

Viking Therapeutics Statistics

Total Valuation

VKTX has a market cap or net worth of $4.42 billion. The enterprise value is $3.75 billion.

Market Cap	4.42B
Enterprise Value	3.75B

Important Dates

The last earnings date was Wednesday, October 22, 2025, after market close.

Earnings Date	Oct 22, 2025
Ex-Dividend Date	n/a

Share Statistics

VKTX has 113.04 million shares outstanding. The number of shares has increased by 5.48% in one year.

Current Share Class	113.04M
Shares Outstanding	113.04M
Shares Change (YoY)	+5.48%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	2.17%
Owned by Institutions (%)	63.98%
Float	110.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.15
P/TBV Ratio	6.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 28.34, with a Debt / Equity ratio of 0.00.

Current Ratio	28.34
Quick Ratio	27.41
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3,435.53

Financial Efficiency

Return on equity (ROE) is -29.23% and return on invested capital (ROIC) is -21.12%.

Return on Equity (ROE)	-29.23%
Return on Assets (ROA)	-20.48%
Return on Invested Capital (ROIC)	-21.12%
Return on Capital Employed (ROCE)	-38.53%
Revenue Per Employee	n/a
Profits Per Employee	-$6.59M
Employee Count	36
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.97% in the last 52 weeks. The beta is 0.63, so VKTX's price volatility has been lower than the market average.

Beta (5Y)	0.63
52-Week Price Change	-28.97%
50-Day Moving Average	31.55
200-Day Moving Average	29.46
Relative Strength Index (RSI)	61.24
Average Volume (20 Days)	4,595,542

Short Selling Information

The latest short interest is 25.45 million, so 22.52% of the outstanding shares have been sold short.

Short Interest	25.45M
Short Previous Month	27.54M
Short % of Shares Out	22.52%
Short % of Float	23.03%
Short Ratio (days to cover)	4.97

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-274.84M
Pretax Income	-237.39M
Net Income	-237.39M
EBITDA	n/a
EBIT	-274.84M
Earnings Per Share (EPS)	-$2.12

Balance Sheet

The company has $714.57 million in cash and $755,000 in debt, giving a net cash position of $713.82 million or $6.31 per share.

Cash & Cash Equivalents	714.57M
Total Debt	755,000
Net Cash	713.82M
Net Cash Per Share	$6.31
Equity (Book Value)	713.03M
Book Value Per Share	6.34
Working Capital	712.64M

Cash Flow

Operating Cash Flow	-224.58M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VKTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.48%
Shareholder Yield	-5.48%
Earnings Yield	-5.32%
FCF Yield	n/a

Analyst Forecast

The average price target for VKTX is $87.07, which is 122.63% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$87.07
Price Target Difference	122.63%
Analyst Consensus	Strong Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	2.19%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1